ERIN DOHLMAN: Open Payments
NPI 1578121075 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 88 payments from 20 companies in 2025. Trend: 2023 $1,132 · 2024 $1,446 · 2025 $1,585
Food & beverage: $1,567Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $279 |
| PFIZER INC. | 17 | $272 |
| ABBVIE INC. | 10 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $135 |
| Novo Nordisk Inc | 5 | $110 |
| Phathom Pharmaceuticals, Inc. | 7 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Lundbeck LLC | 3 | $58 |
Products named: FARXIGA, JARDIANCE, NURTEC ODT, REXULTI, VOQUEZNA, UBRELVY, Kerendia, ELIQUIS.
Industry payments across IA — which companies pay providers there.
